Literature DB >> 34505527

Antioxidative effect of dietary flavonoid isoquercitrin on human ovarian granulosa cells HGL5 in vitro.

A Kolesarova1, K Michalcova, S Roychoudhury, S Baldovska, E Tvrda, J Vasicek, P Chrenek, L Sanislo, V Kren.   

Abstract

This study aimed to examine the effect of dietary flavonoid isoquercitrin on ovarian granulosa cells using the immortalized human cell line HGL5. Cell viability, survival, apoptosis, release of steroid hormones 17beta-estradiol and progesterone, and human transforming growth factor-beta2 (TGF-beta2) and TGF-beta2 receptor as well as intracellular reactive oxygen species (ROS) generation were investigated after isoquercitrin treatment at the concentration range of 5-100 microg.ml-1. It did not cause any significant change (p>0.05) in cell viability as studied by AlamarBlue assay in comparison to control. No significant change was observed (p>0.05) in the proportion of live, dead and apoptotic cells as revealed by apoptotic assay using flow cytometry. Similarly, the release of 17beta-estradiol, progesterone, TGF-beta2 and its receptor were not affected significantly (p>0.05) by isoquercitrin as detected by ELISA, in comparison to control. Except for the highest concentration of 100 microg.ml-1, which led to oxidative stress, isoquercitrin exhibited antioxidative activity at lower concentration used in the study (5, 10, 25, and 50 microg.ml-1) by hampering the production of intracellular ROS, in comparison to control, as detected by chemiluminescence assay (p<0.05). Findings of the present study indicate an existence of the antioxidative pathway that involves inhibition of intracellular ROS generation by isoquercitrin in human ovarian granulosa cells.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34505527      PMCID: PMC8820525          DOI: 10.33549/physiolres.934692

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  35 in total

Review 1.  Ovarian granulosa cell lines.

Authors:  Jon C Havelock; William E Rainey; Bruce R Carr
Journal:  Mol Cell Endocrinol       Date:  2004-12-30       Impact factor: 4.102

Review 2.  Isoquercitrin: pharmacology, toxicology, and metabolism.

Authors:  Kateřina Valentová; Jiří Vrba; Martina Bancířová; Jitka Ulrichová; Vladimír Křen
Journal:  Food Chem Toxicol       Date:  2014-03-27       Impact factor: 6.023

3.  Effects of A.marina-Derived Isoquercitrin on TNF-Related Apoptosis-Inducing Ligand Receptor (TRAIL-R) Expression and Apoptosis Induction in Cervical Cancer Cells.

Authors:  Sathishkumar Arumugam; Kapil Bandil; Peter Proksch; Kalaiselvam Murugiyan; Mausumi Bharadwaj
Journal:  Appl Biochem Biotechnol       Date:  2016-12-24       Impact factor: 2.926

Review 4.  Oxidative stress, inflammation, and cancer: how are they linked?

Authors:  Simone Reuter; Subash C Gupta; Madan M Chaturvedi; Bharat B Aggarwal
Journal:  Free Radic Biol Med       Date:  2010-09-16       Impact factor: 7.376

5.  In vitro response of human ovarian cancer cells to dietary bioflavonoid isoquercitrin.

Authors:  Katarina Michalcova; Shubhadeep Roychoudhury; Marek Halenar; Eva Tvrda; Eva Kovacikova; Jaromir Vasicek; Peter Chrenek; Simona Baldovska; Luboslav Sanislo; Vladimir Kren; Adriana Kolesarova
Journal:  J Environ Sci Health B       Date:  2019-07-04       Impact factor: 1.990

6.  Follicle-restricted compartmentalization of transforming growth factor beta superfamily ligands in the feline ovary.

Authors:  Sarah K Bristol; Teresa K Woodruff
Journal:  Biol Reprod       Date:  2003-12-03       Impact factor: 4.285

7.  Hepatoprotective effect of isoquercitrin against acetaminophen-induced liver injury.

Authors:  Wenyan Xie; Meng Wang; Chen Chen; Xiaoying Zhang; Matthias F Melzig
Journal:  Life Sci       Date:  2016-04-03       Impact factor: 5.037

8.  Characterization and identification of human immortalized granulosa cells derived from ovarian follicular fluid.

Authors:  Ai Ai; Zhengya Tang; Yali Liu; Sha Yu; Bin Li; He Huang; Xiangsheng Wang; Yilin Cao; Wenjie Zhang
Journal:  Exp Ther Med       Date:  2019-07-23       Impact factor: 2.447

9.  Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I Trial.

Authors:  Carlo Buonerba; Pietro De Placido; Dario Bruzzese; Martina Pagliuca; Paola Ungaro; Davide Bosso; Dario Ribera; Simona Iaccarino; Luca Scafuri; Antonietta Liotti; Valeria Romeo; Michela Izzo; Francesco Perri; Beniamino Casale; Giuseppe Grimaldi; Francesca Vitrone; Arturo Brunetti; Daniela Terracciano; Alfredo Marinelli; Sabino De Placido; Giuseppe Di Lorenzo
Journal:  Front Pharmacol       Date:  2018-03-16       Impact factor: 5.810

10.  Isoquercitrin Inhibits Hydrogen Peroxide-Induced Apoptosis of EA.hy926 Cells via the PI3K/Akt/GSK3β Signaling Pathway.

Authors:  Meixia Zhu; Jiankuan Li; Ke Wang; Xuliang Hao; Rui Ge; Qingshan Li
Journal:  Molecules       Date:  2016-03-21       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.